Clinical Trial

Nuwiq for Perioperative Management Of Patients With Haemophilia A on Emicizumab Regular Prophylaxis Study

Study acronym: NuPOWER
Recruiting Phase 4
View on ClinicalTrials.gov →
Summary
Recombinant factor VIII for the prevention of bleeding in patients with severe haemophilia A undergoing major surgery while receiving emicizumab prophylaxis
Protocol Amendment History 8 amendments
This ClinicalTrials.gov record has been amended 8 times since 2023-07-03; most recent amendment 2026-05-08.
Status change: Not Yet Recruiting → Recruiting 2024-01-24
Trial Details
NCT Number NCT05935358
Lead Sponsor Octapharma
Conditions Severe Hemophilia A
Enrollment 28 participants
Start Date 2023-11-28
Primary Completion 2026-08 (estimated)
Study Completion 2026-09 (estimated)
Updated on ClinicalTrials.gov 2026-05-12